Pacira Pharmaceuticals News
Most Popular Pacira Pharmaceuticals Story
Pacira Pharmaceuticals - Biotech IPOs of 2011
Company: Pacira Pharmaceuticals ($PCRX)Based: San DiegoRaised: $42M (6M shares at $7)Target range: $14 to $16Current price: $7.99 San Diego-based pain management company Pacira Pharmaceuticals had Read more...
Latest Headlines
- January 17, 2012
- October 31, 2011
- February 3, 2011
- March 2, 2009
- November 17, 2008
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
